BROOMFIELD, CO – April 20, 2015 – Colorado Therapeutics, LLC, a privately held emerging medical device company, has been created to leverage over 15 years of innovative and proprietary tissue processing technology. The Company has developed innovative and disruptive xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications. To provide more information on the company, technology, and products in development, the company has launched a new website.
The Company’s proprietary cross linked tissue processing technology produces extremely strong, durable, and biocompatible tissue from xenogenic sources that demonstrate superior benefits compared to currently available biologic or synthetic products. Colorado Therapeutics is developing products for multiple indications to target the $2.25 Billion U.S. soft tissue reinforcement and regeneration markets. Products in development include abdominal wall reconstruction, orthopedic, and other applications that can benefit from the company’s proprietary technology.
Colorado Therapeutics corporate headquarters and pre-commercialization facilities are located in Broomfield, Colorado. For more information on Colorado Therapeutics technology and career opportunities, please visit the Colorado Therapeutics website at www.co-therapeutics.com.
Corporate and Media Relations Contact:
Telephone: (303) 469-9459